US Patent 7837994 Use of anti-IL-20 antibody for treating osteoporosis
Patent 7837994 was granted and assigned to National Cheng Kung University on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+161 characters)
Article
Patent abstract
Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Ming-Shi Chang0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07837994 Use of anti-IL-20 antibody for treating osteoporosis US Patent 7837994 Use of anti-IL-20 antibody for treating osteoporosis
Infobox
Patent Number
078379940
Patent Number
78379940
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078379940
Date of Patent
November 23, 2010
0Patent Application Number
122467150
Date Filed
October 7, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07837994 Use of anti-IL-20 antibody for treating osteoporosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07837994
Date of patent
November 23, 2010
Patent application number
12246715
Date Filed
October 7, 2008
Patent primary examiner
Find more entities like US Patent 7837994 Use of anti-IL-20 antibody for treating osteoporosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
